OLDWICK, N.J., Feb. 19, 2020 /PRNewswire/ -- Provention Bio,
Inc. (Nasdaq: PRVB), a clinical-stage biopharmaceutical company
dedicated to intercepting and preventing immune-mediated diseases,
today announced that management will present at two upcoming
conferences:
- The 9th Annual SVB Leerink Global Healthcare
Conference on Wednesday, February 26,
2020, at 10:00 am E.T. The conference is being
held at the Lotte New York Palace Hotel, New York,
NY.
- The 40th Annual Cowen Health Care Conference on
Monday, March 2, 2020, at
4:50 pm E.T. The conference is being
held at the Boston Marriott Copley Place, Boston, MA.
Each presentation will be webcast live and can be accessed by
visiting the Events and Webcasts section of the Company's
website: http://investors.proventionbio.com/events. Each
webcast will be archived on the Company's website for 90 days
following the presentation.
About Provention Bio, Inc.
Provention Bio, Inc. (Nasdaq: PRVB) is a clinical-stage
biopharmaceutical company leveraging a transformational drug
development strategy that is focused on the prevention or
interception of immune-mediated disease. Provention's mission
is to in-license, transform and develop therapeutic candidates
targeting the high morbidity, mortality and escalating costs of
autoimmune and inflammatory diseases including: type 1 diabetes
(T1D), celiac disease and lupus. Provention's diversified portfolio
includes advanced-stage product development candidates that have
undergone clinical testing by other companies.
Investors:
Sam Martin,
Argot Partners
sam@argotpartners.com
212-600-1902
Media:
David Rosen
david.rosen@argotpartners.com
212-600-1902
View original content to download
multimedia:http://www.prnewswire.com/news-releases/provention-bio-to-present-at-upcoming-conferences-301006966.html
SOURCE Provention Bio, Inc.